Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

News feed

Drones attacked Lukoil oil platform in the Caspian Sea

12/11/25 LKOH

Magnit will put autonomous trucks on regular flights

12/11/25 MGNT

Polyus has confirmed its production forecast for 2025

12/11/25 PLZL

Ukrainian drones attacked the Dorogobuzh plant

12/11/25 DGBZ

Ukrainian drone attacked Akron factories

12/11/25 AKRN

Sber In 2026 will open the possibility of purchasing CFAs through Sberbank Online

12/11/25 SBER

Lenta could have paid for 67% of Remy 10-15 billion

12/10/25 LENT

Shareholders of Novorossiysk Bakery Products Plant approved dividends

12/10/25 NKHP

Shareholders of Perm Energy Supply Company approved dividends

12/10/25 PMSB

Yandex AI will determine the construction sites of the Rosatom nuclear power plant

12/10/25 YDEX